Bipartisan FDA User Fee Reauthorization Is Good Starting Point
Wednesday, April 25, 2012
WASHINGTON, D.C. – Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Tom Harkin (D-Iowa) and Ranking Member Senator Mike Enzi (R-Wyo.) today said the Committee’s markup of FDA user fee reauthorization reflected a strong bipartisan effort.
“Today’s markup of the user fee agreement reauthorizations was an important step,” said Harkin and Enzi. “At a time when Congress has been deeply divided, today’s markup displayed strong bipartisan cooperation.”
Harkin and Enzi noted that this legislation builds upon the current user fee programs, which will expire in September. If new drug and medical device user fee agreements are not authorized before current ones expire, FDA must lay off nearly 2,000 employees. This would derail the premarket review programs, threatening patient access to new therapies, biomedical industry jobs, and America’s global leadership in biomedical innovation.
“In addition to user fees, this bill will reauthorize programs that have helped make medicines safer for millions of children, upgrade FDA’s tools to police the global drug supply chain and ensure that American patients get better access to safe, innovative medical devices and medicines,” said Harkin and Enzi. “This measure will also help reduce the risk of drug shortages.”
# # #
- Harkin Statement on President’s Speech Addressing Income Inequality, Need to Raise Minimum Wage [Chairman]
- On International Day of Persons with Disabilities, Harkin Renews Call for Senate to Ratify Convention on the Rights of Persons with Disabilities [Chairman]
- Alexander Bill to Reduce Premature Births Signed Into Law [Ranking Member]
- Alexander Compounding Legislation Signed Into Law to Help “Prevent Another Nightmare for Tennesseans Like Last Year’s Terrifying Meningitis Outbreak” [Ranking Member]
- Harkin: Signing of Bipartisan Health Bills is Culmination of Major HELP Committee Efforts [Chairman]
- Alexander Statement on Supreme Court Agreement To Review Obamacare Religious Freedom Case [Ranking Member]